TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro

In ovarian cancer patients, chemotherapy resistance is the principal factor restricting long-term treatment. Paclitaxel (Pac) has been previously reported to be a ligand to Toll-like receptor 4 (TLR4). It was determined that TLR4 signaling is divided into the following two pathways: Myeloid differen...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, AN-CONG, MA, YUE-BING, WU, FENG-XIA, MA, ZHI-FANG, LIU, NAI-FU, GAO, RONG, GAO, YONG-SHENG, SHENG, XIU-GUI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919821/
https://www.ncbi.nlm.nih.gov/pubmed/24527095
http://dx.doi.org/10.3892/ol.2013.1759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919821/
https://www.ncbi.nlm.nih.gov/pubmed/24527095
http://dx.doi.org/10.3892/ol.2013.1759

Ejemplares similares